Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Immunomodulatory Treatment on IVF Outcomes in Patients With KIRR AA Genotype: a Retrospective Cohort Study With Implications for Personalized Fertility Strategies

NCT06264206 is registered in ClinicalTrials.gov with Calla IVF Center as lead sponsor.

NCT NCT06264206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06264206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Immunomodulatory Treatment on IVF Outcomes in Patients With KIRR AA Genotype: a Retrospective Cohort Study With Implications for Personalized Fertility Strategies
Lead sponsor
Calla IVF Center
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2022
Completion date
December 31, 2023
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunomodulatory drugs, killer-cell immunoglobulin-like receptors (kirs), kir alleles (kir aa)